Dyne raises $233M in 19th Mass. IPO this year

Amid a parade of upsized biotech IPOs this year, a Waltham company working on drugs to treat muscle diseases made its debut with a $233 million fundraise today — more than double what it said it was hoping to bring in when it first filed its plans last month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
#